FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Enalapril maleate and hydrochlorothiazide from Taro Pharmaceuticals U.S.A., Inc. to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Enalapril Maleate and Hydrochlorothiazide (enalapril maleate and hydrochlorothiazide)

Snippet

SUPPL AP for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)